Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does radioiodine therapy for hyperthyroidism increase long-term morbidity?

Nature Clinical Practice Endocrinology & Metabolism volume 4, pages 252–253 (2008)Cite this article

boxed-text Metso S et al. (2007) Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin Endocrinol (Oxf) [doi: 10.1111/j.1365-2265.2007.03064.x]

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hodgson SF et al. (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9: 544–564

    Article  Google Scholar 

  2. Bischoff-Ferrari HA et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18–28

    Article  CAS  Google Scholar 

  3. Nelson HD et al. (2002) Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 137: 529–541

    Article  Google Scholar 

  4. Metso S et al. (2007) Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 92: 2190–2196

    Article  CAS  Google Scholar 

  5. Dobyns BM et al. (1974) Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol. Metab 38: 976–998

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Endocrine Section, Washington Hospital Center, 110 Irving Street, NW, Washington, DC 20010-2975, USA kenneth.d.burman@medstar.net

Authors and Affiliations

  1. Department of Medicine, KD Burman is the Chief of the Endocrine Section, Washington Hospital Center, and a Professor of Medicine, Georgetown University, Washington, DC, USA.,

    Kenneth D Burman

Authors
  1. Kenneth D Burman
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burman, K. Does radioiodine therapy for hyperthyroidism increase long-term morbidity?. Nat Rev Endocrinol 4, 252–253 (2008). https://doi.org/10.1038/ncpendmet0780

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0780

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing